Egypt
Hepatitis B
Download HBV dataHBV elimination goal
National prevalence survey within the last 5 years
Not Adopted
Estimates of economic burden
Not Adopted
System for monitoring testing and treatment
Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2015
Recommendations for HBV testing of pregnant women
Adopted
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Adopted
HBV testing policy
Risk-based
No patient co-pays for HBsAg testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: Simplified treatment and monitoring algorithm for primary care providers
Not Adopted
Simplified care: No treatment co-pays
Adopted
Adult HBV vaccination policy for high-risk populations
Partially Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2020
National prevalence survey within the last 5 years
Not Adopted
Estimates of economic burden
Adopted
System for monitoring testing and treatment
Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Eligible for HCV generic medicines
Registration of generic HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
HCV testing policy
Universal
No patient co-pays for anti-HCV testing
Adopted
National treatment guidelines exist
Simplified care: Less than 2 clinic visits during treatment
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Adopted
No genotyping
Adopted
National policy for harm reduction for persons who inject drugs
Partially Adopted
National policy for syringe exchange in federal prisons
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Public budget line for testing and treatment
Adopted
Hepatitis C
Download HCV dataHBV elimination goal
National prevalence survey within the last 5 years
Not Adopted
Estimates of economic burden
Not Adopted
System for monitoring testing and treatment
Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2015
Recommendations for HBV testing of pregnant women
Adopted
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Adopted
HBV testing policy
Risk-based
No patient co-pays for HBsAg testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: Simplified treatment and monitoring algorithm for primary care providers
Not Adopted
Simplified care: No treatment co-pays
Adopted
Adult HBV vaccination policy for high-risk populations
Partially Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2020
National prevalence survey within the last 5 years
Not Adopted
Estimates of economic burden
Adopted
System for monitoring testing and treatment
Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Eligible for HCV generic medicines
Registration of generic HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Adopted
HCV testing policy
Universal
No patient co-pays for anti-HCV testing
Adopted
National treatment guidelines exist
Simplified care: Less than 2 clinic visits during treatment
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Adopted
No genotyping
Adopted
National policy for harm reduction for persons who inject drugs
Partially Adopted
National policy for syringe exchange in federal prisons
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Public budget line for testing and treatment
Adopted
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Modelled
HBV
19,190
2019
(11,665 - 28,385)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
18,000
2019
Communication with Egyptian National Liver Institute
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
0.20
(%)
2020, latest modelled
(0.17 - 0.24(%))
WHO
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines
